Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04562129
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2020-09-18
Brief Title:
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Organization Data
Organization:
H Lee Moffitt Cancer Center and Research Institute
Class:
OTHER
Study ID:
MCC-20494
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Clinigen Inc | INDUSTRY |